Professor Paul Lockhart is the Group Leader of Neurogenetic Research and Co-Director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute.
Paul received his PhD in Genetics (Title: Molecular analysis of copper transport in sheep) from the University of Melbourne in 2000. He was awarded a NHMRC CJ Martin Fellowship to study the genetics of neurodegenerative disorders, specifically Parkinson's disease, with Professor John Hardy (2000-2001) and Professor Matthew Farrer (2002-2003) at The Mayo Clinic, Florida. He returned to Australia in 2004 and joined the newly formed Bruce Lefroy Centre (BLC) at Murdoch Children's Research Institute, with the aim of establishing a laboratory research group to complement the clinical and public health research activities of the BLC. He received a NHMRC RD Wright Fellowship in 2005 and was appointed Co-Director of the BLC in 2009.
Paul initiated a new research direction in 2009, utilising new sequencing technologies to identify genes causing neurogenetic disorders and was awarded a NHMRC CDA2 Fellowship in 2012 and Vincent Chiodo Foundation Fellowship in 2019. His research has identified 26 causal and >100 risk genes for genetic disorders in the last decade, delineating new pathways to disease and translating these research findings to improved diagnostics, treatment and prevention of disease.
Professor Paul Lockhart is the Group Leader of Neurogenetic Research and Co-Director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute.
Paul received his PhD in Genetics (Title: Molecular analysis of copper transport in sheep)...
Professor Paul Lockhart is the Group Leader of Neurogenetic Research and Co-Director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute.
Paul received his PhD in Genetics (Title: Molecular analysis of copper transport in sheep) from the University of Melbourne in 2000. He was awarded a NHMRC CJ Martin Fellowship to study the genetics of neurodegenerative disorders, specifically Parkinson's disease, with Professor John Hardy (2000-2001) and Professor Matthew Farrer (2002-2003) at The Mayo Clinic, Florida. He returned to Australia in 2004 and joined the newly formed Bruce Lefroy Centre (BLC) at Murdoch Children's Research Institute, with the aim of establishing a laboratory research group to complement the clinical and public health research activities of the BLC. He received a NHMRC RD Wright Fellowship in 2005 and was appointed Co-Director of the BLC in 2009.
Paul initiated a new research direction in 2009, utilising new sequencing technologies to identify genes causing neurogenetic disorders and was awarded a NHMRC CDA2 Fellowship in 2012 and Vincent Chiodo Foundation Fellowship in 2019. His research has identified 26 causal and >100 risk genes for genetic disorders in the last decade, delineating new pathways to disease and translating these research findings to improved diagnostics, treatment and prevention of disease.
Top Publications
Taft, RJ, Vanderver, A, Leventer, RJ, Damiani, SA, Simons, C, Grimmond, SM, Miller, D, Schmidt, J, Lockhart, PJ, Pope, K, et al.
Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity..
Am J Hum Genet
92(5)
:
774 -780
2013
view publication
Yiu, E, Tai, G, Peverill, R, Lee, K, Croft, K, Mori, T, Stephenson, S, Lockhart, P, Sarsero, J, Churchyard, A, et al.
An Open Label Clinical Pilot Study of Resveratrol as a Treatment for Friedreich Ataxia (S43.006).
Neurology
80(7_supplement)
:
2013
view publication
Taylor, JM, Brody, KM, Lockhart, PJ.
Parkin co-regulated gene is involved in aggresome formation and autophagy in response to proteasomal impairment..
Exp Cell Res
318(16)
:
2059 -2070
2012
view publication
Matthews, N, Vance, A, Cummins, TDR, Wagner, J, Connolly, A, Yamada, J, Lockhart, PJ, Panwar, A, Wallace, RH, Bellgrove, MA.
The COMT Val158 allele is associated with impaired delayed-match-to-sample performance in ADHD..
Behav Brain Funct
8:
25
2012
view publication
Delatycki, MB, Wolthuizen, M, Collins, V, Varley, E, Craven, J, Allen, KJ, Gurrin, LC, Aitken, M, Trembath, MK, Bond, L, et al.
ironXS: high-school screening for hereditary haemochromatosis is acceptable and feasible..
Eur J Hum Genet
20(5)
:
505 -509
2012
view publication